Aztiq Pharma Partners S.a r.l. 13D and 13G filings for Alvotech:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-12 4:09 pm Purchase | 2025-12-17 | 13D | ALVOTECH S A ALVO | Aztiq Pharma Partners S.a r.l. | 103,849,420 33.300% | 2,701,617 (+2.67%) | Filing |
| 2024-07-03 5:31 pm Unchanged | 2024-07-01 | 13D | ALVOTECH S A ALVO | Aztiq Pharma Partners S.a r.l. | 101,147,803 33.500% | 0 (Unchanged) | Filing |
| 2022-07-18 4:03 pm Purchase | 2022-07-12 | 13D | ALVOTECH S A ALVO | Aztiq Pharma Partners S.a r.l. | 101,147,803 40.680% | 2,500,000 (+2.53%) | Filing |
| 2022-07-01 6:19 pm Purchase | 2022-06-15 | 13D | ALVOTECH S A ALVO | Aztiq Pharma Partners S.a r.l. | 98,647,803 40.490% | 98,647,803 (New Position) | Filing |